A report on the company at the end of last year by rating agency Fitch noted that in 2021 Roche was marketing 15 drugs with $1 billion-plus sales, up from nine in 2017. With an additional 15 ...
The new indication adds to the 2021 approval of Susvimo (ranibizumab) for 'wet' or neovascular age-related macular ...
The Roche Holdings Inc.-Bond was issued on the 12/13/2021 with a volume of 2 B. USD. Indices Commodities Currencies Stocks ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback